The Vanguard Group 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:16 pm Purchase |
2023-12-29 | 13G | Vaxcyte, Inc. PCVX |
The Vanguard Group | 8,452,371 8.880% |
1,838,705 (+27.80%) |
Filing |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Vaxcyte, Inc. PCVX |
The Vanguard Group | 6,613,666 8.370% |
3,479,380 (+111.01%) |
Filing |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
The Vanguard Group | 3,134,286 5.940% |
3,134,286 (New Position) |
Filing |